Stay updated with breaking news from Nasdaq Adma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ADMA Biologics (NASDAQ:ADMA – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a report issued on Tuesday, Benzinga reports. They presently have a $6.00 price objective on the biotechnology company’s stock. Cantor Fitzgerald’s target price would indicate a potential upside of 46.70% from the stock’s current price. ADMA has been […]
ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) – Cantor Fitzgerald raised their FY2024 EPS estimates for shares of ADMA Biologics in a note issued to investors on Thursday, November 9th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biotechnology company will post earnings per share of $0.18 for the year, up from their previous […]
ADMA Biologics (NASDAQ:ADMA – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Wednesday, November 8th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link. ADMA […]
StockNews.com downgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a hold rating to a sell rating in a report issued on Sunday morning. Several other analysts have also recently commented on ADMA. TheStreet upgraded ADMA Biologics from a d rating to a c- rating in a report on Friday, May 19th. Cantor Fitzgerald […]
StockNews.com upgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a sell rating to a hold rating in a research report report published on Saturday. Other research analysts also recently issued research reports about the stock. Mizuho lifted their price target on shares of ADMA Biologics from $6.00 to $7.00 in a research note […]